NO166409C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.

Info

Publication number
NO166409C
NO166409C NO862487A NO862487A NO166409C NO 166409 C NO166409 C NO 166409C NO 862487 A NO862487 A NO 862487A NO 862487 A NO862487 A NO 862487A NO 166409 C NO166409 C NO 166409C
Authority
NO
Norway
Prior art keywords
branched
straight
alkyl
optionally substituted
different
Prior art date
Application number
NO862487A
Other languages
English (en)
Other versions
NO862487L (no
NO862487D0 (no
NO166409B (no
Inventor
Mario Pinza
Ugo Pfeiffer
Carlo Farina
Silvano Banfi
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of NO862487D0 publication Critical patent/NO862487D0/no
Publication of NO862487L publication Critical patent/NO862487L/no
Publication of NO166409B publication Critical patent/NO166409B/no
Publication of NO166409C publication Critical patent/NO166409C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO862487A 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. NO166409C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21236/85A IT1222367B (it) 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico

Publications (4)

Publication Number Publication Date
NO862487D0 NO862487D0 (no) 1986-06-20
NO862487L NO862487L (no) 1986-12-22
NO166409B NO166409B (no) 1991-04-08
NO166409C true NO166409C (no) 1991-07-24

Family

ID=11178826

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862487A NO166409C (no) 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.

Country Status (18)

Country Link
US (1) US4703054A (no)
EP (1) EP0207680B1 (no)
JP (1) JPH0688979B2 (no)
KR (1) KR870000305A (no)
AT (1) ATE56020T1 (no)
AU (1) AU590283B2 (no)
CA (1) CA1273450A (no)
DE (1) DE3673709D1 (no)
DK (1) DK290386A (no)
FI (1) FI862422A7 (no)
GR (1) GR861578B (no)
HU (1) HUT41741A (no)
IL (1) IL79138A (no)
IT (1) IT1222367B (no)
NO (1) NO166409C (no)
NZ (1) NZ216552A (no)
PH (2) PH23229A (no)
ZA (1) ZA864446B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
JP2606026B2 (ja) * 1991-07-09 1997-04-30 コクヨ株式会社 フォルダー
RU2142470C1 (ru) * 1998-12-22 1999-12-10 Анохина Ирина Петровна Тетрапептид trp-nle-asp-phenh-ch(ch3)2, обладающий антиалкогольной активностью
CA2397644A1 (en) * 2000-01-18 2001-07-26 The Regents Of The University Of California Acid addition salts of imidazolidinones as reaction catalysts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449029A (de) * 1963-08-12 1967-12-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.

Also Published As

Publication number Publication date
FI862422A7 (fi) 1986-12-22
US4703054A (en) 1987-10-27
JPS6230763A (ja) 1987-02-09
IT1222367B (it) 1990-09-05
GR861578B (en) 1986-10-21
DK290386D0 (da) 1986-06-20
EP0207680A3 (en) 1989-01-18
KR870000305A (ko) 1987-02-17
PH24336A (en) 1990-06-13
AU590283B2 (en) 1989-11-02
IL79138A (en) 1991-04-15
FI862422A0 (fi) 1986-06-06
EP0207680A2 (en) 1987-01-07
EP0207680B1 (en) 1990-08-29
CA1273450A (en) 1990-08-28
NO862487L (no) 1986-12-22
NO862487D0 (no) 1986-06-20
DE3673709D1 (de) 1990-10-04
IT8521236A0 (it) 1985-06-21
NO166409B (no) 1991-04-08
PH23229A (en) 1989-06-06
DK290386A (da) 1987-02-11
HUT41741A (en) 1987-05-28
ZA864446B (en) 1987-03-25
JPH0688979B2 (ja) 1994-11-09
NZ216552A (en) 1989-11-28
AU5891786A (en) 1986-12-24
ATE56020T1 (de) 1990-09-15

Similar Documents

Publication Publication Date Title
IL74631A (en) 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them
NO168173C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater
NO168428C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat
IL79138A (en) Substituted imidazolidinones,their preparation and pharmaceutical compositions containing them
GR3007498T3 (no)